Presentation
EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL OVER 4 YEARS IN PSORIATIC ARTHRITIS PATIENTS WITH AND WITHOUT CONCOMITANT USE OF DMARDS. British Society for Rheumatology (BSR), Liverpool, May 2018.
British Society for Rheumatology (BSR)
(2018)
Disciplines
Publication Date
May, 2018
Citation Information
R Cooper, J Walsh and Philip Mease. "EFFICACY AND SAFETY OF CERTOLIZUMAB PEGOL OVER 4 YEARS IN PSORIATIC ARTHRITIS PATIENTS WITH AND WITHOUT CONCOMITANT USE OF DMARDS. British Society for Rheumatology (BSR), Liverpool, May 2018." British Society for Rheumatology (BSR) (2018) Available at: http://works.bepress.com/philip-mease/148/